26095-59-0 Usage
Description
Otilonium bromide is an antispasmodic agent characterized by its red color ACh (acetylcholine) like moiety bound to an aromatic system that ends with an octyl ether. It functions as an inhibitor of L-type and T-type calcium channels and acts as an antagonist of muscarinic acetylcholine receptors (mAChRs) and the platelet activating factor (PAF) receptor.
Used in Pharmaceutical Industry:
Otilonium bromide is used as a spasmolytic agent for the treatment of gastrointestinal spasm, providing relief from muscle contractions and cramping in the digestive system.
Used in Cardiovascular Applications:
Otilonium bromide is used as an antimuscarinic to inhibit platelet activating factor induced hypotension, helping to maintain stable blood pressure and prevent sudden drops that can be dangerous.
Used in Pain Management:
Otilonium bromide is used as an analgesic, leveraging its platelet-activating factor antagonist properties to help alleviate pain.
Used in Anti-Inflammatory Treatments:
Otilonium bromide is used as an anti-inflammatory agent, reducing inflammation and associated discomfort.
Used in Gynecological Applications:
Otilonium bromide is used to inhibit uterine contractions, which can be beneficial in managing certain gynecological conditions or during specific procedures.
Used in Antitumor Applications:
Otilonium bromide is used as an anti-tumor agent, potentially contributing to cancer treatment strategies by leveraging its platelet-activating factor antagonist characteristics.
Chemical Properties:
Otilonium bromide is a white powder, highlighting its suitability for various pharmaceutical formulations.
Pharmacological effects
Otilonium bromide is an anticholinergic and antispasmodic drug. Its trade name is Siba Min. It can regulate the flow of calcium between intestinal smooth muscle extracellular and intracellular calcium pools. It is selective to gastrointestinal smooth muscle, and it has strong antispasmodic effect. It is applied to all motor function hyperthyroidism, and spasm reaction for different reasons and different parts as well as smooth muscle fibers pathological atrophy caused spasm reaction. It is also applied to the treatment of gastrointestinal distal intestine irritable bowel syndrome (IBS) or spastic pain, spastic colon, gastroenteritis, stomach, duodenum and esophagus disease, and endoscopic examination preparation (esophagoscopy, gastroscopy, ten finger colonoscopy and proctoscope). The experimental data show that the drug is absorbed very little by oral medication, and the most absorbed drug passed the biliary tract and were excreted via the stool.
The above information is edited by the lookchem of Kui Ming.
Toxicology
Acute toxicity: Non-lethal dose of oral administration to rats 1500mg/kg, to dogs is 1000mg/kg.
Chronic toxicity: experimental animals according to the program: 180 days of continuous oral administration, 11.44mg/kg/otilonium bromide. We found no abnormal changes in the results of blood biochemical and histological examination.
Teratogenicity: according to 11.44mg/kg, no embryonic and teratogenic toxicity to rats and rabbits in experiments.
Gene mutations: a large number of experiments have shown no mutagenic effect.
Side effects
Therapeutic doses of otilonium bromide doesn’t cause side effects, and it doesn’t cause atropine-like effect.
Precautions
Patients with glaucoma, prostatic hypertrophy, pyloric stenosis, pregnant or lactating women, and patients known allergic reaction to otilonium bromide should be used with caution.
Therapeutic Function
Anticholinergic, Spasmolytic
Biochem/physiol Actions
Otilonium Bromide is a muscarinic receptor antagonist (antimuscarinic). Otilonium Bromide is a quaternary ammonium salt that exerts spasmolytic action selective on the distal gastrointestinal tract. It is used world-wide for the treatment of irritable bowel syndrome (IBS).
Safety Profile
Poison by intraperitoneal route. Moderately toxic by ingestion and subcutaneous routes. When heated to decomposition it emits toxic fumes of Brí and NOx.
Check Digit Verification of cas no
The CAS Registry Mumber 26095-59-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,0,9 and 5 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 26095-59:
(7*2)+(6*6)+(5*0)+(4*9)+(3*5)+(2*5)+(1*9)=120
120 % 10 = 0
So 26095-59-0 is a valid CAS Registry Number.
InChI:InChI=1/C28H40N2O4.BrH/c1-5-8-9-10-13-21-33-26-15-12-11-14-25(26)27(31)29-24-18-16-23(17-19-24)28(32)34-22-20-30(4,6-2)7-3;/h11-12,14-19H,5-10,13,20-22H2,1-4H3;1H
26095-59-0Relevant articles and documents
ANTIBIOTIC AMMONIUM COMPOUNDS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS
-
, (2020/08/22)
The present disclosure provides ammonium compounds, e.g., compounds according to Formula I as set forth herein, which are useful as antimicrobial agents. Methods for the treatment of bacterial infections and associated conditions, e.g., gastrointestinal conditions, are also described, as well as methods for altering the microbiome of subjects such as humans.